MAB1663 Search Results


mo anti human rd systems mab1663  (R&D Systems)
93
R&D Systems mo anti human rd systems mab1663
List of the 20 proteins quantified using the Reverse Phase Protein Array (RPPA) technique. The suppliers and conditions for each primary antibody used in this study after western blotting validation are given.
Mo Anti Human Rd Systems Mab1663, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/MAB1663/Human%2FMouse%2FRat+HSP70%2FHSPA1A+Antibody/pmc05994332-13-7-9
Average 93 stars, based on 1 article reviews
mo anti human rd systems mab1663 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
hsp70  (R&D Systems)
99
R&D Systems hsp70
T-PNU displays immunogenic cell death properties. a , EMT6-hHER2 cell death kinetics induced by T-PNU. Percentage of early (annexin V + /DAPI − ) and late (annexin V + /DAPI + ) apoptotic cells and necrotic cells (annexin V − /DAPI + ) was determined by flow cytometry. Data presented as mean ± SD for 3 independent experiments. b , Representative dot plots of flow cytometry analysis of cell death induced by T-PNU, idarubicine and UVB radiation at indicated time points. c , T-PNU induction of <t>HSP70,</t> HSP90 and CRT on EMT6-hHER2 cells. UVB treated cells are used as controls. Experiments were performed in triplicates. d , Representative immunofluorescence staining of HSP70, HSP90 and CRT on EMT6-hHER2 following T-PNU treatment. The presence of indicated markers on the cell surface was verified by confocal microscopy. e , T-PNU induces oxidative stress and production of reactive oxygen species (ROS). ROS were stained by CellRox Deep Red reagent and detected by flow cytometry. Experiments were performed in triplicates. f , Quantification of intracellular or extracellular ATP levels in EMT6-hHER2 cell line exposed to T-PNU, idarubicine and UVB. Data presented as mean ± SD for 3 independent experiments. g , HMGB1 release into EMT6-hHER2 culture supernatants induced by T-PNU. The compiled results of a total of 3 experiments are shown
Hsp70, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/MAB1663/Human%2FMouse%2FRat+HSP70%2FHSPA1A+Antibody/pmc06341578-43-0-1
Average 99 stars, based on 1 article reviews
hsp70 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
human mouse rat hsp70 hspa1a antibody  (Bio-Techne corporation)
94
Bio-Techne corporation human mouse rat hsp70 hspa1a antibody
Immunoblots of retinal antigens with sera from healthy controls and patients affected by RP. Each panel represents a different capillary Western blot run on four separate sets of controls and patients with RP. In the first five columns in each panel, the bands corresponding to the recombinant proteins are identified by the blot with the respective specific antibodies: size marker (lane 1), human recombinant enolase (lane 2), <t>HSP70</t> (lane 3), human recombinant CAII (lane 4), and a mix of enolase, HSP70, and CAII (lane 5).
Human Mouse Rat Hsp70 Hspa1a Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/MAB1663/Human%2FMouse%2FRat+HSP70%2FHSPA1A+Antibody/pmc10720755-145-5-15
Average 94 stars, based on 1 article reviews
human mouse rat hsp70 hspa1a antibody - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


List of the 20 proteins quantified using the Reverse Phase Protein Array (RPPA) technique. The suppliers and conditions for each primary antibody used in this study after western blotting validation are given.

Journal: PeerJ

Article Title: Beef tenderness and intramuscular fat proteomic biomarkers: muscle type effect

doi: 10.7717/peerj.4891

Figure Lengend Snippet: List of the 20 proteins quantified using the Reverse Phase Protein Array (RPPA) technique. The suppliers and conditions for each primary antibody used in this study after western blotting validation are given.

Article Snippet: Hsp70-1A ( HSPA1A ) , Q27975 , Mo. anti-human RD Systems MAB1663 , 1/1000.

Techniques: Protein Array, Western Blot, Biomarker Discovery, Protein Binding

T-PNU displays immunogenic cell death properties. a , EMT6-hHER2 cell death kinetics induced by T-PNU. Percentage of early (annexin V + /DAPI − ) and late (annexin V + /DAPI + ) apoptotic cells and necrotic cells (annexin V − /DAPI + ) was determined by flow cytometry. Data presented as mean ± SD for 3 independent experiments. b , Representative dot plots of flow cytometry analysis of cell death induced by T-PNU, idarubicine and UVB radiation at indicated time points. c , T-PNU induction of HSP70, HSP90 and CRT on EMT6-hHER2 cells. UVB treated cells are used as controls. Experiments were performed in triplicates. d , Representative immunofluorescence staining of HSP70, HSP90 and CRT on EMT6-hHER2 following T-PNU treatment. The presence of indicated markers on the cell surface was verified by confocal microscopy. e , T-PNU induces oxidative stress and production of reactive oxygen species (ROS). ROS were stained by CellRox Deep Red reagent and detected by flow cytometry. Experiments were performed in triplicates. f , Quantification of intracellular or extracellular ATP levels in EMT6-hHER2 cell line exposed to T-PNU, idarubicine and UVB. Data presented as mean ± SD for 3 independent experiments. g , HMGB1 release into EMT6-hHER2 culture supernatants induced by T-PNU. The compiled results of a total of 3 experiments are shown

Journal: Journal for Immunotherapy of Cancer

Article Title: A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer

doi: 10.1186/s40425-018-0464-1

Figure Lengend Snippet: T-PNU displays immunogenic cell death properties. a , EMT6-hHER2 cell death kinetics induced by T-PNU. Percentage of early (annexin V + /DAPI − ) and late (annexin V + /DAPI + ) apoptotic cells and necrotic cells (annexin V − /DAPI + ) was determined by flow cytometry. Data presented as mean ± SD for 3 independent experiments. b , Representative dot plots of flow cytometry analysis of cell death induced by T-PNU, idarubicine and UVB radiation at indicated time points. c , T-PNU induction of HSP70, HSP90 and CRT on EMT6-hHER2 cells. UVB treated cells are used as controls. Experiments were performed in triplicates. d , Representative immunofluorescence staining of HSP70, HSP90 and CRT on EMT6-hHER2 following T-PNU treatment. The presence of indicated markers on the cell surface was verified by confocal microscopy. e , T-PNU induces oxidative stress and production of reactive oxygen species (ROS). ROS were stained by CellRox Deep Red reagent and detected by flow cytometry. Experiments were performed in triplicates. f , Quantification of intracellular or extracellular ATP levels in EMT6-hHER2 cell line exposed to T-PNU, idarubicine and UVB. Data presented as mean ± SD for 3 independent experiments. g , HMGB1 release into EMT6-hHER2 culture supernatants induced by T-PNU. The compiled results of a total of 3 experiments are shown

Article Snippet: HSP70 (R&D Systems, #RD-MAB1663), HSP90 (Enzo Life Sciences, #ADI-SPA-830-F) and CRT antibody (Abcam, #ab2907) were used for flow cytometry.

Techniques: Flow Cytometry, Immunofluorescence, Staining, Confocal Microscopy

Immunoblots of retinal antigens with sera from healthy controls and patients affected by RP. Each panel represents a different capillary Western blot run on four separate sets of controls and patients with RP. In the first five columns in each panel, the bands corresponding to the recombinant proteins are identified by the blot with the respective specific antibodies: size marker (lane 1), human recombinant enolase (lane 2), HSP70 (lane 3), human recombinant CAII (lane 4), and a mix of enolase, HSP70, and CAII (lane 5).

Journal: Investigative Ophthalmology & Visual Science

Article Title: Association of Circulating Antiretinal Antibodies With Clinical Outcomes in Retinitis Pigmentosa

doi: 10.1167/iovs.64.15.13

Figure Lengend Snippet: Immunoblots of retinal antigens with sera from healthy controls and patients affected by RP. Each panel represents a different capillary Western blot run on four separate sets of controls and patients with RP. In the first five columns in each panel, the bands corresponding to the recombinant proteins are identified by the blot with the respective specific antibodies: size marker (lane 1), human recombinant enolase (lane 2), HSP70 (lane 3), human recombinant CAII (lane 4), and a mix of enolase, HSP70, and CAII (lane 5).

Article Snippet: Mouse enolase 1 antibody H00002023-M01, human/mouse/rat HSP70/HSPA1A antibody, rabbit anti–carbonic anhydrase II/CA2 antibody NB600-919 (Novusbio Bio-techne) were diluted to an optimized concentration in Ab diluent (1:1000, 1:400, and 1:200, respectively).

Techniques: Western Blot, Recombinant, Marker

Bar graphs depicting the distributions of serum positivity to circulating ARAs against CAII, enolase, and HSP70 in controls and patients affected by RP.

Journal: Investigative Ophthalmology & Visual Science

Article Title: Association of Circulating Antiretinal Antibodies With Clinical Outcomes in Retinitis Pigmentosa

doi: 10.1167/iovs.64.15.13

Figure Lengend Snippet: Bar graphs depicting the distributions of serum positivity to circulating ARAs against CAII, enolase, and HSP70 in controls and patients affected by RP.

Article Snippet: Mouse enolase 1 antibody H00002023-M01, human/mouse/rat HSP70/HSPA1A antibody, rabbit anti–carbonic anhydrase II/CA2 antibody NB600-919 (Novusbio Bio-techne) were diluted to an optimized concentration in Ab diluent (1:1000, 1:400, and 1:200, respectively).

Techniques:

Bar graphs depicting the distributions of serum positivity to circulating ARAs against CAII, enolase, and HSP70 in patients affected by RP, according to the presence of cystoid macular edema or vitreomacular interface disorders (epiretinal membrane and/or lamellar macular hole).

Journal: Investigative Ophthalmology & Visual Science

Article Title: Association of Circulating Antiretinal Antibodies With Clinical Outcomes in Retinitis Pigmentosa

doi: 10.1167/iovs.64.15.13

Figure Lengend Snippet: Bar graphs depicting the distributions of serum positivity to circulating ARAs against CAII, enolase, and HSP70 in patients affected by RP, according to the presence of cystoid macular edema or vitreomacular interface disorders (epiretinal membrane and/or lamellar macular hole).

Article Snippet: Mouse enolase 1 antibody H00002023-M01, human/mouse/rat HSP70/HSPA1A antibody, rabbit anti–carbonic anhydrase II/CA2 antibody NB600-919 (Novusbio Bio-techne) were diluted to an optimized concentration in Ab diluent (1:1000, 1:400, and 1:200, respectively).

Techniques: Membrane